By Aveluro Research Team · Editorial policy
DHT (DHT) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 63,500 VND, little changed on the session, giving a market capitalization of 5.8 trillion VND.
On valuation, DHT trades at a price-to-earnings ratio of 131.2 and a price-to-book of 5.2. That is a premium to the Health Care sector average P/E of 25.9. Return on equity of 3.9% points to weak profitability relative to the company's equity base, below the sector average of 8.1%. Trailing earnings per share stand at 487 VND.
Aveluro tracks 5 news items mentioning DHT, where recent coverage skews negative (40% of articles). The most recent catalyst was a foreign flow event — "Foreign Investors Net Sell VND 562B on June 2, Buy FPT Nearly VND 500B". Aveluro's composite model rates DHT 5.2/10 (Hold), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 6,963 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AMV, CVN and DAN.
What matters now
Foreign Investors Net Sell VND 562B on June 2, Buy FPT Nearly VND 500B
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Want to trade DHT? Compare brokers for Vietnam stocks.
Foreign investors need a broker that can handle Vietnam market access, settlement, custody, and foreign ownership limits.
Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.